Belite Bio, Inc American Depositary Shares (BLTE) is a publicly traded Healthcare sector company. As of October 19, 2026, BLTE trades at $143.01 with a market cap of $5.75B and a P/E ratio of 0.00. BLTE moved +0.16% today. Year to date, BLTE is -10.74%; over the trailing twelve months it is +60.30%. Its 52-week range spans $49.00 to $200.00. Analyst consensus is strong buy with an average price target of $236.86. Rallies surfaces BLTE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover BLTE: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $236.86.
| Metric | Value |
|---|---|
| Price | $143.01 |
| Market Cap | $5.75B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $200.00 |
| 52-Week Low | $49.00 |
| Volume | 2.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
7 analysts cover BLTE: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $236.86.